SG155251A1 - Process for production of 1-(3-(2-(1-benzothiophen-5-yl)- ethoxy)propyl)azetidin-3-ol or salts thereof - Google Patents

Process for production of 1-(3-(2-(1-benzothiophen-5-yl)- ethoxy)propyl)azetidin-3-ol or salts thereof

Info

Publication number
SG155251A1
SG155251A1 SG200905724-1A SG2009057241A SG155251A1 SG 155251 A1 SG155251 A1 SG 155251A1 SG 2009057241 A SG2009057241 A SG 2009057241A SG 155251 A1 SG155251 A1 SG 155251A1
Authority
SG
Singapore
Prior art keywords
benzothiophen
azetidin
ethoxy
propyl
salts
Prior art date
Application number
SG200905724-1A
Other languages
English (en)
Inventor
Akihito Saitoh
Yoshiaki Suzuki
Kenji Yonezawa
Mitsuhide Kawamura
Takahiko Kusanagi
Takashi Nakai
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of SG155251A1 publication Critical patent/SG155251A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/64Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG200905724-1A 2005-03-28 2006-03-27 Process for production of 1-(3-(2-(1-benzothiophen-5-yl)- ethoxy)propyl)azetidin-3-ol or salts thereof SG155251A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2005090831 2005-03-28
JP2005174738 2005-06-15
JP2005206808 2005-07-15
JP2005230666 2005-08-09

Publications (1)

Publication Number Publication Date
SG155251A1 true SG155251A1 (en) 2009-09-30

Family

ID=37053344

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200905724-1A SG155251A1 (en) 2005-03-28 2006-03-27 Process for production of 1-(3-(2-(1-benzothiophen-5-yl)- ethoxy)propyl)azetidin-3-ol or salts thereof

Country Status (22)

Country Link
US (2) US7951963B2 (pl)
EP (4) EP2210884B1 (pl)
JP (1) JP5031554B2 (pl)
KR (2) KR101337382B1 (pl)
CN (1) CN101151257B (pl)
AT (2) ATE546443T1 (pl)
AU (1) AU2006229271B2 (pl)
BR (1) BRPI0609496C8 (pl)
CA (2) CA2799659C (pl)
CY (3) CY1112956T1 (pl)
DK (2) DK2248809T3 (pl)
ES (3) ES2380443T3 (pl)
IL (2) IL186044A (pl)
MX (1) MX2007011938A (pl)
NO (3) NO340071B1 (pl)
NZ (2) NZ583580A (pl)
PL (3) PL2248809T3 (pl)
PT (3) PT2248809E (pl)
SG (1) SG155251A1 (pl)
SI (3) SI2348022T1 (pl)
WO (1) WO2006104088A1 (pl)
ZA (1) ZA200708262B (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0213393B8 (pt) 2001-10-19 2021-05-25 Fujifilm Toyama Chemical Co Ltd derivados de éter alquílico, ou um de seus sais, processo para produzir um derivado de éter alquílico, derivado de alquil-amida, ou um de seus sais, e, composição farmacêutica
PL2248809T3 (pl) * 2005-03-28 2012-10-31 Toyama Chemical Co Ltd 3-[2-(Benzo[b]tiofen-5-ylo)-etoksy]-propaniany alkilu jako związki pośrednie w wytwarzaniu pochodnych azetydyn-3-olu
JP4902247B2 (ja) * 2005-04-08 2012-03-21 富山化学工業株式会社 2−(1−ベンゾチオフェン−5−イル)エタノールの新規製造法およびその中間体
CA2869945C (en) 2006-04-07 2018-01-23 Vertex Pharmaceuticals Incorporated Modulators of atp-binding cassette transporters
US10022352B2 (en) 2006-04-07 2018-07-17 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
US7645789B2 (en) 2006-04-07 2010-01-12 Vertex Pharmaceuticals Incorporated Indole derivatives as CFTR modulators
SI2048145T1 (sl) * 2006-08-04 2011-04-29 Toyama Chemical Co Ltd Spodbujevalec aktivnosti proteinske kinaze c, vsebujoäś derivat alkilnega etra ali sol le-tega
US8563573B2 (en) 2007-11-02 2013-10-22 Vertex Pharmaceuticals Incorporated Azaindole derivatives as CFTR modulators
JP5763313B2 (ja) * 2009-09-03 2015-08-12 富山化学工業株式会社 2−(1−ベンゾチオフェン−5−イル)エタノールの製造法
JP5592205B2 (ja) * 2009-09-03 2014-09-17 富山化学工業株式会社 (1−ベンゾチオフェン−5−イル)酢酸またはその塩の製造法
US8802868B2 (en) 2010-03-25 2014-08-12 Vertex Pharmaceuticals Incorporated Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
MX2012012204A (es) * 2010-04-22 2012-12-05 Vertex Pharma Proceso para producir compuestos de cicloalquilcarboxamido-indol.
JP6004307B2 (ja) * 2010-07-26 2016-10-05 富山化学工業株式会社 3−(2−(1−ベンゾチオフェン−5−イル)エトキシ)プロピオン酸の塩またはその水和物およびその製造法
BR112013022282B1 (pt) 2011-03-02 2019-03-26 Bayer Intellectual Property Gmbh Processo para a preparação de derivados de ácidos aril- e heteroaril acético
WO2013047786A1 (ja) 2011-09-30 2013-04-04 日本化成株式会社 重合性無機粒子分散剤、該重合性無機粒子分散剤を含む無機有機複合粒子、および無機有機樹脂複合材
TR201907882T4 (tr) 2012-02-22 2019-06-21 Fujifilm Toyama Chemical Co Ltd 1-(3-(2-(1-Benzotiofen-5-il)etoksi)propil)azetidin-3-olü veya onun tuzunu içeren katı farmasötik bileşim
AR092857A1 (es) 2012-07-16 2015-05-06 Vertex Pharma Composiciones farmaceuticas de (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-il)-n-(1-(2,3-dihidroxipropil)-6-fluoro-2-(1-hidroxi-2-metilpropan-2-il)-1h-indol-5-il)ciclopropancarboxamida y administracion de las mismas
EP3100725B1 (en) 2014-01-31 2020-05-06 FUJIFILM Toyama Chemical Co., Ltd. Post nerve injury rehabilitation effect-enhancing agent comprising an alkyl ether derivative or a salt thereof
CN110840847B (zh) 2014-04-15 2022-07-29 沃泰克斯药物股份有限公司 用于治疗囊性纤维化跨膜传导调节因子介导的疾病的药物组合物
US11236062B2 (en) 2016-03-31 2022-02-01 Fujifilm Toyama Chemical Co., Ltd. Method for producing 5-(bromomethyl)-1-benzothiophene

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL72070A (en) 1983-06-20 1988-11-30 Merck & Co Inc 2-sulfamoylbenzo(b)-thiophene derivatives,their preparation and pharmaceutical compositions containing them
ZA844616B (en) 1983-06-20 1986-02-26 Merck & Co Inc 2-sulfamoylbenzo(b)thiophene derivatives for the treatment of elevated intraocular pressure
US4668697A (en) 1983-10-31 1987-05-26 Merck & Co., Inc. Elevated intraocular pressure lowering benzo-[b]-thiophene-2-sulfonamide derivatives, compositions, and method of use therefor
CH673100A5 (pl) 1987-08-10 1990-02-15 Josef Paul Huser
JPH04182463A (ja) 1990-11-17 1992-06-30 Sumitomo Seika Chem Co Ltd ハロゲノチオフェノール類およびその誘導体の製造方法
JPH05140086A (ja) 1991-09-26 1993-06-08 Sumitomo Seika Chem Co Ltd ハロゲノチオフエノールの製造方法および精製方法
JPH05178816A (ja) 1991-12-28 1993-07-20 Sumitomo Seika Chem Co Ltd ハロゲノチオフェノールの製造方法
JP2641363B2 (ja) 1992-04-22 1997-08-13 三共株式会社 新規なフェネチルアルコール及びその製法
GB9404775D0 (en) 1994-03-11 1994-04-27 Payne P P Ltd Improvements in or relating to article tagging
JPH08143533A (ja) 1994-11-24 1996-06-04 Sumitomo Seika Chem Co Ltd ハロチオフェノール類の製造方法
JPH1043967A (ja) 1996-08-06 1998-02-17 Calsonic Corp カシメ装置
AU6519798A (en) 1997-03-31 1998-10-22 Toyama Chemical Co. Ltd. Process for producing 2-(benzo{b}thiophen-5-yl)-2-hydroxyacetic acid derivatives, optically active compounds thereof, or salts of both
GB9706574D0 (en) 1997-04-01 1997-05-21 Zeneca Ltd Cyano substituted cycloalkanes
JPH1112238A (ja) 1997-06-23 1999-01-19 Kao Corp 1−(β−ヒドロキシエチル)−2,5−ジアミノベンゼン又はその塩の製造法
JPH1143455A (ja) 1997-07-25 1999-02-16 Mitsubishi Chem Corp ハロゲン化アルコールの製造方法
WO1999031056A1 (fr) 1997-12-12 1999-06-24 Toyama Chemical Co., Ltd. Derives d'ether alcoylique ou leurs sels, et antagonistes du calcium les contenant
EP0993105B1 (en) 1998-10-07 2003-01-08 STMicroelectronics S.r.l. Control of power transfer in a flyback converter by modulating the off-phase in function of the load
JP4182463B2 (ja) 2000-07-19 2008-11-19 富士電機デバイステクノロジー株式会社 磁気ディスク評価装置およびその方法
WO2002100850A1 (fr) 2001-06-08 2002-12-19 Kuraray Co., Ltd. Procedes de preparation de composes heterocycliques
BRPI0213393B8 (pt) 2001-10-19 2021-05-25 Fujifilm Toyama Chemical Co Ltd derivados de éter alquílico, ou um de seus sais, processo para produzir um derivado de éter alquílico, derivado de alquil-amida, ou um de seus sais, e, composição farmacêutica
CA2521648C (en) * 2003-04-17 2012-07-03 Toyama Chemical Co., Ltd. Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof
JP2005012291A (ja) 2003-06-17 2005-01-13 National Institute Of Information & Communication Technology Tv会議用モバイル動画通信端末
US20050032873A1 (en) 2003-07-30 2005-02-10 Wyeth 3-Amino chroman and 2-amino tetralin derivatives
WO2005019200A2 (en) 2003-08-14 2005-03-03 Icos Corporation Aryl piperidine derivatives as vla-1 integrin antagonists and uses thereof
PL2248809T3 (pl) 2005-03-28 2012-10-31 Toyama Chemical Co Ltd 3-[2-(Benzo[b]tiofen-5-ylo)-etoksy]-propaniany alkilu jako związki pośrednie w wytwarzaniu pochodnych azetydyn-3-olu
MX2008013728A (es) 2006-04-26 2009-01-07 Toyama Chemical Co Ltd Inductor de neurogenesis o agente terapeutico de neuropatia que abarca el derivado del eter alkilico o sal del mismo.

Also Published As

Publication number Publication date
PT2210884E (pt) 2012-04-10
JPWO2006104088A1 (ja) 2008-09-04
AU2006229271A1 (en) 2006-10-05
KR20130010090A (ko) 2013-01-25
ATE546443T1 (de) 2012-03-15
BRPI0609496C1 (pt) 2021-05-11
NZ583580A (en) 2010-10-29
CY1113571T1 (el) 2016-06-22
KR101337382B1 (ko) 2013-12-06
PT2248809E (pt) 2012-07-02
PL2210884T3 (pl) 2012-07-31
KR20080008334A (ko) 2008-01-23
CA2600381C (en) 2013-11-12
EP1864978A4 (en) 2009-07-01
IL214245A (en) 2014-12-31
CN101151257A (zh) 2008-03-26
EP2248809A1 (en) 2010-11-10
IL186044A0 (en) 2008-02-09
EP2348022B1 (en) 2013-01-09
IL186044A (en) 2013-12-31
SI2348022T1 (sl) 2013-05-31
ES2398934T3 (es) 2013-03-22
NO340071B1 (no) 2017-03-06
SI2210884T1 (sl) 2012-06-29
EP2210884B1 (en) 2012-02-22
ES2380443T3 (es) 2012-05-11
BRPI0609496B1 (pt) 2020-11-24
ES2384312T3 (es) 2012-07-03
CA2600381A1 (en) 2006-10-05
WO2006104088A1 (ja) 2006-10-05
IL214245A0 (en) 2011-08-31
ATE557020T1 (de) 2012-05-15
NO340366B1 (no) 2017-04-10
EP2210884A2 (en) 2010-07-28
BRPI0609496C8 (pt) 2021-05-25
EP2248809B1 (en) 2012-05-09
EP1864978A1 (en) 2007-12-12
BRPI0609496A2 (pt) 2011-10-18
JP5031554B2 (ja) 2012-09-19
DK2248809T3 (da) 2012-06-18
PL2248809T3 (pl) 2012-10-31
US20110098484A1 (en) 2011-04-28
CA2799659A1 (en) 2006-10-05
US20090069576A1 (en) 2009-03-12
EP2348022A1 (en) 2011-07-27
EP2210884A3 (en) 2010-09-22
NZ561672A (en) 2010-04-30
PT2348022E (pt) 2013-02-13
CN101151257B (zh) 2012-07-18
US8273902B2 (en) 2012-09-25
CY1112956T1 (el) 2016-04-13
PL2348022T3 (pl) 2013-06-28
SI2248809T1 (sl) 2012-09-28
NO340420B1 (no) 2017-04-18
NO20074618L (no) 2007-10-25
ZA200708262B (en) 2009-01-28
US7951963B2 (en) 2011-05-31
NO20161419A1 (no) 2016-06-07
CA2799659C (en) 2014-12-02
DK2210884T3 (da) 2012-03-26
KR101283930B1 (ko) 2013-07-16
AU2006229271B2 (en) 2012-02-09
CY1112885T1 (el) 2016-04-13
NO20161418A1 (no) 2007-10-25
MX2007011938A (es) 2008-03-14

Similar Documents

Publication Publication Date Title
SG155251A1 (en) Process for production of 1-(3-(2-(1-benzothiophen-5-yl)- ethoxy)propyl)azetidin-3-ol or salts thereof
SI1801082T1 (sl) Postopek za izdelavo anorganskih vlaken
EP2040910A4 (en) CALING METHOD FOR PRODUCING AN OPTICAL FILM
PL2088218T3 (pl) Blacha stalowa gruba o wysokim module Younga i sposób jej wytwarzania
ZA200809453B (en) Process for producing bleached pulp
EP1976844A4 (en) IMPROVED METHOD FOR PURE DULOXETIN HYDROCHLORIDE
EP2067348A4 (en) VARIABLE CONVERSATION RECORDING METHOD
PT3061866T (pt) Processo de fabrico de papel ou cartão
EP1900720A4 (en) PROCESS FOR PRODUCING SUBSTITUTED CYCLOPENTANONE
ZA200805231B (en) Process for making diaryl carbonate
SG136920A1 (en) Process for producing methionine
FR2910500B1 (fr) Procede de fabrication d'un papier calque
TW200734321A (en) Benzo [b] thiophen derivatives and a process for producing benzo [b] thiophen derivatives
EP2332932A4 (en) NEW CRYSTALLINE FORMS OF 4- (2-AMINOPYRIDIN-4-YL) -3- (4-fluoro-PHENYL) -1- (1,4,5,6-TETRAHYDRO-6-OXOPYRIDAZIN-3-YL) -1H-PYRAZOLE -METHANESULPHONATE AND METHOD OF MANUFACTURING THEREOF
EP1930325A4 (en) METHOD FOR PRODUCING AN OPTICALLY ACTIVE PIPERAZINE COMPOUND
DK2348022T3 (da) Fremgangsmåde til fremstilling af 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol eller salte deraf
EP2226310A4 (en) PROCESS FOR PRODUCING 2- (1-HYDROXYALKYL) CYCLOALCANONE
EP2077259A4 (en) PROCESS FOR THE PRODUCTION OF 2,6-DIMETHYL-1-NAPHTHALDEHYDE
EP2226325A4 (en) PROCESS FOR THE PRODUCTION OF 4- (PHENYL-SUBSTITUTED) HEXAHYDROPYRIDOÝ2,1-CÝÝ1,4¨OXAZIN-6-ONE
EP1953150A4 (en) PROCESS FOR THE MANUFACTURE OF 2- (4-METHYL-2-PHENYLPIPERAZIN-1-YL) PYRIDINE-3-METHANOL
ZA200810321B (en) Crystalline (3-cyano-1H-indol-7-yl)-[4-(4-fluorophenethyl) piperazin-1-yl]methanone phosphate
PL379536A3 (pl) Sposób wytwarzania 3-[2-(2-dipropyloaminoetylo)-6-nitrofenylo]-2-oksopropionianu etylu